相关实验视频
Updated: Sep 18, 2025

09:11
Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
6.7K
含有胺的素脱乙酶抑制剂具有抗癌治疗潜力
Juntao Song1, Shujing Si2, Jie Qin2
1Hematology & Oncology Department, Zibo 148 Hospital, China RongTong Medical Healthcare Group Co. Ltd., Zibo, Shandong Province, People's Republic of China.
Archiv der Pharmazie
|June 27, 2025
概括
胺衍生物是具有抗癌潜力的强激素脱乙酶 (HDAC) 抑制剂. 本综述强调了自2020年以来为癌症治疗开发的基于胺的HDAC抑制剂.
科学领域:
- 药用化学 医学化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 基因脱乙酶 (HDACs) 调节关键的细胞过程,包括基因表达,细胞循环和细胞亡.
- HDACs的失调与癌症的发展和进展有关.
- HDAC 抑制剂代表了针对这些酶的有前途的抗癌药物.
研究的目的:
- 审查具有抗癌潜力的含胺HDAC抑制剂.
- 总结一下自2020年以来开发的基于胺的新型HDAC抑制剂.
- 引导未来开发有效的抗癌疗法.
主要方法:
- 科学出版物和专利的文献评论.
- 专注于针对HDAC的扎胺衍生物.
- 对抗癌症活性和治疗潜力的分析.
主要成果:
- 胺衍生物通过结合离子并与活性部位残留物相互作用,有效抑制HDACs.
- 这些抑制剂通过多种机制表现出抗癌活性,包括基因表达调节和亡诱导.
- 最近的发展表明,含胺的HDAC抑制剂对癌症治疗具有前景.
结论:
- 胺衍生物是有价值的HDAC抑制剂,具有显著的抗癌治疗潜力.
- 对胺基HDAC抑制剂的持续研究对于开发新型癌症疗法至关重要.
- 这些化合物为利用HDACs在癌症治疗中提供了合理的方法.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
457
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
457
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
574
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
574
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Antihypertensive Drugs: Thiazide-Class Diuretics
901
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
901
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
330
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
330

